In this paper, we demonstrate EGFR is a highly activated kinase in a patient-derived chordoma xenograft, erlotinib and gefitinib inhibit U-CH1 proliferation in vitro, and erlotinib inhibits growth of chordoma in vivo. Here, EGFR is linked to chordoma.